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httpcense.Abstract The management of patients with malignant pleural effusion (MPE) remains problem-
atic. Various modalities are available in the management of MPE. However, optimal treatment is
still controversial and there is no universal standard approach. Management options include obser-
vation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement and pleurodesis.
The aim of the study: To evaluate the efﬁcacy, safety and tolerability of pigtail catheters in
comparison to intercostal tubes in pleurodesis of malignant pleural effusions.
Patients and methods: This study was carried out at Chest Department, Zagazig University
Hospitals during the period from January 2012 to September 2013. The study included 100 patients
(39 males and 61 females with a mean age of 61.8 ± 11.3 years) with pleural effusion of malignant
etiology. Patients were classiﬁed into two groups Group I: included 50 patients 18 males and 32
females with a mean age of 63.8 years who were subjected to pigtail catheter drainage then pleurod-
esis. Group II: included 50 patients 21 males and 29 females with a mean age of 61.8 years who were
subjected to tube thoracotomy drainage then pleurodesis.
Results: As regards pleurodesis outcome, there was a high frequency of success in group I (33
patients, 66%) when compared with group II (27 patients, 54%). However, the difference is not
statistically signiﬁcant. As regards pleurodesis complications the higher frequency of complications1223595477.
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108 A.H.A. Ghoneim et al.was in group II (22 patients, 44%) when compared with group I (43 patients, 86%). These
differences were statistically signiﬁcant (P< 0.05).
Conclusion: Pigtail catheters could be considered a safe, easy, tolerable and effective alternative
method in comparison to the traditional intercostal tubes in pleurodesis of malignant pleural effu-
sions.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
When the pleural effusion has been proved to be malignant
and the patient is not a surgical candidate the type of palliative
therapy is considered, taking into account the patient’s general
condition, symptoms and expected survival [1].
The most cost-effective method of controlling a malignant
pleural effusion is chest tube or catheter drainage and intra-
pleural instillation of a chemical agent. Many antineoplastic
and non-antineoplastic chemical agents have been used for
pleurodesis with variable success. Currently, the most success-
ful and widely used agents include talc by slurry, the tetracy-
clines (minocyclin and doxycyclin) and bleomycin [2].
Tetracycline is a low-cost effective therapy that is easy to use
and has a proven safety record. The recommended dose by
Thomas [3] is one gram of tetracycline hydrochloride in
50 ml of normal saline. Reid and Rudd [4], have recommended
a dose of three grams in 50 ml of normal saline.
The main side effects of tetracycline pleurodesis are fever
and pain [3].
Pigtail catheter is a long, ﬂexible tube that can be guided
into the body. The design of this catheter includes small holes
that allow for drainage and a coiled end that acts to hold the
catheter in place. It can also be used to slow the ﬂow of ﬂuids
injected through the catheter so that they do not burst out in a
jet and cause injuries or obscure a medical imaging study [5].
The aim of the study was to evaluate the efﬁcacy, safety and
tolerability of pigtail catheters in comparison to intercostal
tubes in pleurodesis of malignant pleural effusions.
Patients and methods
This study was carried out at, Chest Department, Zagazig Uni-
versity Hospitals during the period from January 2012 to sep-
tember 2013. The study included 100 consecutive patients (39
males and 61 females with a mean age of 61.8 ± 11.3 years)
who proved to have pleural effusion of malignant etiology.
*These patients were admitted, signed an informed consent, and
subjected to the following
1- Thorough medical history, stressing on smoking history
and history of occupational exposure.
2- Full clinical examination both general and local (chest)
examination.
3- Routine investigations (CBC, ESR, blood sugar, serum
ALT, AST and creatinine) to evaluate the patient gen-
eral condition.
4- Plain chest radiography, Chest computed tomography
(CT). The pleural ﬂuid was considered small, moderate,or massive according to BTS (2003) guidelines for the
investigations of pleural effusion [6].
5- Pleural tapping and the aspirated ﬂuid was sent for
chemical, bacteriological and cytological examinations.
6- Abram pleural biopsy if pleural ﬂuid investigations were
not diagnostic.
7- Thorascopy if Abram pleural biopsy and pleural ﬂuid
investigations were not diagnostic.
8- Fiberoptic bronchoscopy was done in selected cases.
Exclusion criteria
- Atelectasis due to endobronchial obstruction.
- Empyema (pH< 7.2).
- Prior intrapleural therapy.
- Signiﬁcant irradiation to the affected hemithorax.
Patients were classiﬁed into two groups
 Group I (GI): included 50 patients; 18 males and 32 females
with a mean age of 63.8 years, subjected to pigtail catheter
drainage then pleurodesis.
Pigtail catheter insertion
Pigtail catheters were inserted percutaneously using the
Seldinger technique. The pleura was initially punctured with
a hollow needle trocar attached to a syringe; ﬂuid was
aspirated to conﬁrm placement. The syringe was removed
and a guidewire was advanced through the needle lumen.
The guidewire stayed in place while the needle was removed
and a dilator was passed over the guidewire to enlarge the
opening through which the catheter would be placed. Next,
the dilator was removed, the pigtail was uncoiled, and the
catheter was threaded over the guidewire and into the pleural
space. Finally, the guidewire was removed as the distal end of
the catheter curling inside the chest. The catheter was then
connected to a drainage device [7].
 Group (GII): included 50 patients; 21 males and 29 females
with a mean age of 61.8 years, subjected to tube thoracot-
omy drainage then pleurodesis.
Tube thoracotomy
1- An incision about 2 cm was done in the ﬁfth or sixth
intercostal space in the midaxillary line. The incision
was made at the upper border of the rib below, and par-
allel to the rib.
2- A tube and trocar (a sharp-tipped metal rod which
extended through the distal end of the plastic tube) were
inserted into the incision site and forced into the pleural
space under direct pressure and a twisting motion. The
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insertion into the pleural space, the tube was clamped
at the proximal end with forceps.
3- After appropriate positioning, ﬁxation of the tube was
done by the suture; the loose ends of the suture were
wrapped around the end of the tube and tied off,
anchoring the tube to the chest wall. Then dry gauze
and adhesive plaster were applied to cover the wound
and anchor the tube.
4- The chest tube was connected to underwater seal to
allow slow drainage of the effusion, not more than one
liter during the ﬁrst 30 min to avoid post-thoracocentesis
(reexpansion) pulmonary edema [8].
*Pleurodesis
Both groups were subjected to pleurodesis when the ﬂuid in the
catheter or the tube was less than 100 ml on three successive
days with no ﬂuid reaccumulation. 500 mg of tetracycline
mixed with 100 cm3 of sterile saline was used [8].
When the ﬂuid drain decreases (100–150 ml/24 h) or com-
pletely ceases, the chest tube or the catheter would be re-
moved [9].
- Follow up of chest radiographs was done every 24 h till
removal of the tube.
- The patient was discharged and followed up clinically and
radiologically by chest X-ray weekly for one month and
monthly for three months. Pleurodesis would be considered
effective if no effusion relapse occurred within 3 month
period [10].Table 1 Comparison between the studied groups regarding the underlying pathologies.
GI
n= 50
GII
n= 50
Total
n= 100
Chi-square test
X2 P
Metastatic Breast Cancer 20 (40%) 14 (28%) 34 2.5 0.64
Metastatic Lung Cancer 14 (28%) 18 (36) 32
Malignant pleural mesothelioma 8 (16%) 8 (16%) 16
Metastatic gynecological tumors 4(8%) 3(6%) 7
Other tumors 4(8%) 7(14%) 11Table 2 Comparison between the studied groups regarding the ple
Pleural eﬀusion characteristics
Eﬀusion size Small
Moderate
Massive
Pleural ﬂuid cytology for malignant cells +ve
ve
pH 7.26 ± 0.22 7.28 ± 0.22
Protein 4.02 ± 1.58 3.78 ± 1.32
Glucose 96.6 ± 47.05 85.9 ± 53.3
LDH 1271.3 ± 36.8 1277.6 ± 38.6Pigtail catheter insertion, tube thoracotomy and pleurode-
sis were performed by a trained chest physician in the course
of palliative management of cases.
The effectiveness of pleurodesis was considered as follows:
[11]
- Complete response (CR): Total resolution of pleural
effusion.
- Partial response (PR): Appearance of symptomatic loculat-
ed effusion.
- No response (NR): Re-accumulation of pleural effusion
near the same amount seen at presentation.
Statistical analysis
Statistical analysis was performed with SPSS version 19 soft-
ware package (SPSS, Inc. Chicago). P value <0.05 was consid-
ered signiﬁcant.Results
Table 1 shows that metastatic breast cancer represented the
most common cause of malignant pleural effusion in the stud-
ied patients (34%) followed by metastatic lung cancer (32%)
and malignant pleural mesothelioma (16%). No statistically
signiﬁcant differences were found between the studied groups
regarding the frequency of the reported pathologies.
Table 2 shows no statistically signiﬁcant differences be-
tween the studied groups regarding the pleural ﬂuid
characteristics.ural effusion characteristics.
GI
n= 50
GII
n= 50
Total
n= 100
Chi-square test
X2 P
15(30%) 17(34%) 32 0.25 0.88
30(60%) 29(58%) 59
5(10%) 4(8%) 9
34(68%) 39(78%) 73 1.26 0.26
16(32%) 11(22%) 27
Student t test
T P
7.27 ± 0.22 0.35 0.72
3.9 ± 1.45 0.81 0.41
91.2 ± 50.3 1.06 0.28
1274.4 ± 37.6 0.84 0.39
Table 3 comparison between patients with negative pleural
ﬂuid cytology for malignant cells and diagnosed malignant by
other methods.
Group I
N= 16
Group II
N = 11
Total
N = 27
X2 P
Abram’s biopsy 8 (50%) 4 (36.3%) 12(44.4%) 1.02 0.58
Thoracoscope 5 (31.2%) 3 (27.4%) 8(29.6%)
Bronchoscopy 3 (18.8%) 4 (36.3%) 7(25.9%)
110 A.H.A. Ghoneim et al.Table 3 shows that there is no signiﬁcant difference between
groups regarding other methods of diagnosis of malignancy.
(Table 4) as regards pleurodesis outcome, there was a high
frequency of success in GI (33 patients, 66% succeeded) when
compared with GII (27 patients 54%). However, the difference
is not statistically signiﬁcant.
(Table 5) as regards pleurodesis complications there is a
high frequency of complications in GII (22 patients, 44%)Table 5 Comparison between pleurodesis complications in the stud
Pleurodesis complications GI
N= 50
GII
n= 50
N % N
Tachycardia 10 20 18
Pain 5 10 10
Fever 4 8 5
Dyspnea 3 6 7
ARDS – 0 1
Hypotension – 0 1
Mortality – 0 1
Total 22 44 43
Table 4 Comparison between pleurodesis outcome in the studied g
GI
n= 50
GII
n=
Pleurodesis Success 33(66%) 27(54
Failure 17(34%) 23(46
Table 6 Comparison between patients with successful and failed p
Pleural eﬀusion characteristics
Eﬀusion size Small
Moderate
Massive
Pleural ﬂuid cytology for malignant cells +ve
ve
pH 7.31 ± 0.2 7
Protein 3.9 ± 1.67 4
Glucose 89.3 ± 49.9 11
LDH 1273.8 ± 35.2 126when compared with GI (43 patients 86%). These differences
are statistically highly signiﬁcant (P< 0.0004).
Table 6 shows that patients with successful pleurodesis had
signiﬁcantly higher frequency of small and moderate effusions
and signiﬁcantly higher pH when compared with patients with
failed pleurodesis.
Table 7 shows successful pleurodesis was signiﬁcantly high-
er in patients with small to moderate effusions and signiﬁ-
cantly higher pH when compared with patients with failed
pleurodesis.
Discussion
The management of patients with malignant pleural effusion
(MPE) remains problematic. The prognosis of these patients
varies with the histological type of the primary tumor; in gen-
eral, 65% of patients with MPE die within 3 months and 80%
die within 6 months. Signiﬁcant palliation of the dyspnea asso-
ciated with the pleural effusion can be achieved by proceduresied groups.
Total
n= 100
Chi-square test
% N % X2 P
36 28 56 4.5 0.03
20 15 30 1.96 0.16
10 9 18 0.12 0.72
14 10 20 1.77 0.18
2 1 2 1.0 0.31
2 1 2 1.0 0.31
2 1 2 1.0 0.31
86 65 65 13.5 <0.0004
roups.
50
Total
n= 100
Chi-square test
X2 P
%) 60(100%) 1.5 0.22
%) 40(40%)
leurodesis in GI regarding the pleural effusion characteristics.
Success n= 33 Failure n= 17 Chi-square test
X2 P
14 (42.4%) 1 (5.8%) 7.2 0.027*
16 (48.8%) 14 (82.2%)
3 (9%) 2 (11.7%)
20 (60%) 14 (82.3%) 2.4 0.12
13 (39.3%) 3 (17.6%)
Student t test
t P
.16 ± 0.23 2.39 0.02*
.17 ± 1.43 0.47 0.63
0.8 ± 38.4 1.54 0.12
6.2 ± 40.2 0.68 0.49
Table 7 Comparison between patients with successful and failed pleurodesis in GII regarding the pleural effusion characteristics.
Pleural eﬀusion characteristics Success n= 27 Failure n= 23 Chi-square test
X2 P
Eﬀusion size Small 13 4 7.2 0.028*
Moderate 11 18
Massive 3 1
Pleural ﬂuid cytology for malignant cells +ve 19 20 1.99 0.16
ve 8 3
Student t test
t P
pH 7.35 ± 0.2 7.2 ± 0.21 2.54 0.014*
Protein 3.6 ± 1.2 3.9 ± 1.4 0.72 0.47
Glucose 87.8 ± 54.5 83.6 ± 52.8 0.28 0.78
LDH 1274.9 ± 39.8 1280.9 ± 37.8 0.54 0.59
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modalities are available in the management of MPE. Careful
consideration of the patient’s expected survival and quality
of life is needed when deciding the optimum treatment modal-
ity in such patients [13].
However, optimal treatment is still controversial and there
is no universal standard approach. Management options
include observation, thoracentesis, in-dwelling pleural catheter
(IPC) or chest tube placement, pleurodesis, and surgical
pleurectomy [14].
Pleurodesis aims to obliterate the pleural space by produc-
ing extensive adhesion of the visceral and parietal pleura in or-
der to control relapse of either pleural effusions (mostly
malignant) or pneumothorax [15]. Pleurodesis can be induced
through the insertion of pleural catheters, as well as through
surgical procedures (such as thoracotomy). There are various
recommended sclerosing agents, including talc (which is the
most widely used), silver nitrate and, recently, proliferative
cytokines [16]. Thoracostomy tubes are the mainstay of treat-
ment for removing ﬂuid or air from the pleural space. Place-
ment of a chest tube is, however, an invasive procedure with
potential morbidity. Complications include hemothorax, per-
foration of intrathoracic organs, diaphragmatic laceration,
empyema, pulmonary edema, and Horner’s syndrome [17].
Recently, the use of pigtail catheter (ﬂexible and small bore)
by the Seldinger technique has emerged as an effective alterna-
tive for thoracostomy and pleural drainage. Being a less-trau-
matic procedure, this method creates less pain and smaller scar
during and after the placements and possibly fewer procedure-
associated complications [18].
Motivated by these data, the present study aimed to evalu-
ate the efﬁcacy, safety and tolerability of pigtail catheters in
inducing pleurodesis of malignant pleural effusions in compar-
ison with conventional intercostal tubes. To get this target
accomplished, the study recruited 100 patients with malignant
pleural effusions indicating pleurodesis. They were randomly
assigned to one of the equal 50 patients’ therapeutic groups;
GI utilizing the pigtail catheter and GII using the conventional
intercostal tube.
Regarding the reported pathologies in the present study
(Table 1), it was found that that metastatic breast cancer is
the most common cause of malignant pleural effusion in
the studied patients (34.0%) followed by metastatic lung
cancer (32.0%) and malignant pleural mesothelioma(16.0%). No statistically signiﬁcant differences were found
between the studied groups regarding the different reported
pathologies.
This is in harmony with the ﬁndings of Terracciano et al.
[19], who studied new approaches in the diagnostic procedures
of malignant pleural effusions. In their study, 35 malignant
pleural effusions were documented: 13 breast cancers, 12 lung
cancers and 2 mesotheliomas in addition to other primary tu-
mors. Also, in the study of Brega-Massone et al. [20] breast
cancer followed by lung cancer were the commonest locations
of primary cancers in the studied patients.
Regarding the success rate of pleurodesis in the studied
groups (Table 4), the present study reported a success rate of
66.0% in the GI group. This ﬁgure is close to what was found
by Liang et al. [18], who conducted a retrospective review of
adult patients (>/=18 years) who underwent ultrasound-
guided pigtail catheter drainage of pleural effusions in the
ICUs. The reasons for pigtail drainage are as follows: thoracic
empyema (n= 59, 44%), massive transudative pleural effu-
sions (n= 33, 25%), postoperative pleural effusion (n= 29,
15%), malignant pleural effusion (n= 18, 14%) and traumatic
hemothorax (n= 3, 2%).
In the present study, comparison between the studied
groups regarding the success rate had shown a higher success
rate in the GI group; however, the differences are statistically
non signiﬁcant (Table 4).
These results were conﬁrmed by the study of Lin et al. [21]
who conducted a retrospective review of mechanically venti-
lated patients who underwent pigtail catheter drainage as their
initial therapy for malignant pleural effusion in the emergency
department and intensive care unit. In this study, the success
rate of pigtail catheter drainage was 68.6%.
Also, in the study of Aziz et al. [22] the authors concluded
that the use of pigtail catheters is usually very successful in
draining the pleural ﬂuids. Less time consumption, lower cost
and bedside technique make it superior to conventional chest
tube placement in many aspects. However, this was a
retrospective case series that did not include a comparison with
ordinary chest tubes.
However, in another study performed by Cantinet et al. [23]
to evaluate the safety and usefulness of pleural drainage under
radiological guidance for pleural effusion and pneumothorax,
the success rate of pigtail catheters in management of pleural
effusion was as high as 88.0%. However, pleural effusion in
112 A.H.A. Ghoneim et al.this series was a consequence of hepatic disease. In addition,
the tubes were inserted under CT guidance.
Regarding the reported complications in the present study
(Table 5), tachycardia was the most commonly reported com-
plication followed by pain, dyspnea and fever. These data are
similar to that found by Brant and Eaton [24].
Comparison between patients with successful and failed
pleurodesis in GI regarding the pleural effusion characteristics
(Table 6) patients with successful pleurodesis had signiﬁcantly
higher frequency of small to moderate effusions and signiﬁ-
cantly higher pH when compared with patients with failed
pleurodesis. This agrees with Yildirim et al. [25], who found
that pleural ﬂuid pH and volume are signiﬁcant predictors
for successful pleurodesis.
Conclusion
Pigtail catheter could be considered a safe, easy, tolerable and
effective alternative method in comparison to the traditional
intercostal tubes in pleurodesis of malignant pleural effusions.
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